Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 397

1.

miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.

Tang H, Deng M, Tang Y, Xie X, Guo J, Kong Y, Ye F, Su Q, Xie X.

Clin Cancer Res. 2013 Oct 15;19(20):5602-12. doi: 10.1158/1078-0432.CCR-13-1326. Epub 2013 Aug 30.

2.

MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.

Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y, Baba H.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S656-64. doi: 10.1245/s10434-012-2217-6. Epub 2012 Feb 4.

PMID:
22311119
3.

The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.

Zhou X, Wang Y, Shan B, Han J, Zhu H, Lv Y, Fan X, Sang M, Liu XD, Liu W.

Med Oncol. 2015 Jan;32(1):428. doi: 10.1007/s12032-014-0428-3. Epub 2014 Dec 12.

PMID:
25502084
4.

Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells.

Li Y, Nie Y, Tu S, Wang H, Zhou Y, Du Y, Cao J, Ye M.

Oncol Rep. 2016 Oct;36(4):2108-16. doi: 10.3892/or.2016.4996. Epub 2016 Aug 2.

PMID:
27498672
5.

Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.

Kurashige J, Mima K, Sawada G, Takahashi Y, Eguchi H, Sugimachi K, Mori M, Yanagihara K, Yashiro M, Hirakawa K, Baba H, Mimori K.

Carcinogenesis. 2015 Jan;36(1):133-41. doi: 10.1093/carcin/bgu232. Epub 2014 Nov 19.

PMID:
25411357
6.

Inverse association between miR-194 expression and tumor invasion in gastric cancer.

Song Y, Zhao F, Wang Z, Liu Z, Chiang Y, Xu Y, Gao P, Xu H.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S509-17. doi: 10.1245/s10434-011-1999-2. Epub 2011 Aug 16.

PMID:
21845495
7.

Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.

Cui H, Wang L, Gong P, Zhao C, Zhang S, Zhang K, Zhou R, Zhao Z, Fan H.

PLoS One. 2015 Apr 15;10(4):e0123926. doi: 10.1371/journal.pone.0123926. eCollection 2015.

8.

Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.

Zuberi M, Mir R, Das J, Ahmad I, Javid J, Yadav P, Masroor M, Ahmad S, Ray PC, Saxena A.

Clin Transl Oncol. 2015 Oct;17(10):779-87. doi: 10.1007/s12094-015-1303-1. Epub 2015 Jun 11. Erratum in: Clin Transl Oncol. 2015 Oct;17(10):840.

PMID:
26063644
9.

Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.

Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y, Mori M.

Int J Oncol. 2012 May;40(5):1477-82. doi: 10.3892/ijo.2012.1363. Epub 2012 Feb 9.

PMID:
22322911
10.

MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer.

Zuo J, Xia J, Ju F, Yan J, Zhu A, Jin S, Shan T, Zhou H.

Mol Cells. 2013 Apr;35(4):313-9. doi: 10.1007/s10059-013-2314-9. Epub 2013 Mar 29.

11.

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.

Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti GV, Papotti M, Allgayer H.

Mol Cancer Res. 2010 Sep;8(9):1207-16. doi: 10.1158/1541-7786.MCR-10-0052. Epub 2010 Aug 9.

12.

Clinical significance of miR-146a in gastric cancer cases.

Kogo R, Mimori K, Tanaka F, Komune S, Mori M.

Clin Cancer Res. 2011 Jul 1;17(13):4277-84. doi: 10.1158/1078-0432.CCR-10-2866. Epub 2011 Jun 1.

13.

Decreased miR-30b-5p expression by DNMT1 methylation regulation involved in gastric cancer metastasis.

Qiao F, Zhang K, Gong P, Wang L, Hu J, Lu S, Fan H.

Mol Biol Rep. 2014 Sep;41(9):5693-700. doi: 10.1007/s11033-014-3439-4. Epub 2014 Jun 10.

PMID:
24913034
14.

Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.

Yang Q, Zhang C, Huang B, Li H, Zhang R, Huang Y, Wang J.

Eur J Gastroenterol Hepatol. 2013 Aug;25(8):953-7. doi: 10.1097/MEG.0b013e32835ed691.

PMID:
23751352
15.

microRNA-22 acts as a metastasis suppressor by targeting metadherin in gastric cancer.

Tang Y, Liu X, Su B, Zhang Z, Zeng X, Lei Y, Shan J, Wu Y, Tang H, Su Q.

Mol Med Rep. 2015 Jan;11(1):454-60. doi: 10.3892/mmr.2014.2682. Epub 2014 Oct 16.

PMID:
25323629
16.

miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.

Chen Z, Liu S, Tian L, Wu M, Ai F, Tang W, Zhao L, Ding J, Zhang L, Tang A.

Oncotarget. 2015 Nov 10;6(35):38139-50. doi: 10.18632/oncotarget.5709.

17.

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.

Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR, Goel A.

Gut. 2013 Sep;62(9):1315-26. doi: 10.1136/gutjnl-2011-301846. Epub 2012 Jun 26.

18.

miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.

Xie J, Chen M, Zhou J, Mo MS, Zhu LH, Liu YP, Gui QJ, Zhang L, Li GQ.

Oncol Rep. 2014 Apr;31(4):1715-22. doi: 10.3892/or.2014.3052. Epub 2014 Feb 24.

PMID:
24573489
19.

MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer.

Zhu A, Xia J, Zuo J, Jin S, Zhou H, Yao L, Huang H, Han Z.

Med Oncol. 2012 Dec;29(4):2701-9. doi: 10.1007/s12032-011-0134-3. Epub 2011 Dec 14.

PMID:
22167392
20.

Catenin-δ1, negatively regulated by miR-145, promotes tumour aggressiveness in gastric cancer.

Xing AY, Wang YW, Su ZX, Shi DB, Wang B, Gao P.

J Pathol. 2015 May;236(1):53-64. doi: 10.1002/path.4495. Epub 2015 Jan 5.

PMID:
25470111

Supplemental Content

Support Center